Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Rotenberg

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Neural Plasticity|February 17, 2016
N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic YouthJoseph Gonzalez-Heydrich, Michelle Bosquet Enlow, Eugene D'Angelo, et al.
Journal of Neurodevelopmental Disorders|April 24, 2024
Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorderItay Tokatly Latzer, Jean-Baptiste Roullet, Wardiya Afshar-Saber, et al.
Schizophrenia Research|November 10, 2015
Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sampleJoseph Gonzalez-Heydrich, Michelle Bosquet Enlow, Eugene D'Angelo, et al.
Translational Psychiatry|May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulationPatricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Molecular Genetics and Metabolism|March 24, 2026
A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsyGerard T Berry, E Naomi Vos, Didem Demirbas, et al.
Nature|July 16, 2015
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathyAsami Kondo, Koorosh Shahpasand, Rebekah Mannix, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitorSameer C Dhamne, Meera E Modi, Audrey Gray, et al.
Brain Stimulation|July 24, 2017
Response to letter to the editor: Safety of transcranial direct current stimulation: Evidence based update 2016Marom Bikson, Pnina Grossman, Adantchede Louis Zannou, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Neural Plasticity|February 17, 2016
N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic YouthJoseph Gonzalez-Heydrich, Michelle Bosquet Enlow, Eugene D'Angelo, et al.
Journal of Neurodevelopmental Disorders|April 24, 2024
Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorderItay Tokatly Latzer, Jean-Baptiste Roullet, Wardiya Afshar-Saber, et al.
Schizophrenia Research|November 10, 2015
Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sampleJoseph Gonzalez-Heydrich, Michelle Bosquet Enlow, Eugene D'Angelo, et al.
Translational Psychiatry|May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulationPatricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Molecular Genetics and Metabolism|March 24, 2026
A patient with a rare metabolic disease and myo-inositol administration leading to a new treatment for epilepsyGerard T Berry, E Naomi Vos, Didem Demirbas, et al.
Nature|July 16, 2015
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathyAsami Kondo, Koorosh Shahpasand, Rebekah Mannix, et al.
Annals of Clinical and Translational Neurology|August 7, 2023
Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitorSameer C Dhamne, Meera E Modi, Audrey Gray, et al.
Brain Stimulation|July 24, 2017
Response to letter to the editor: Safety of transcranial direct current stimulation: Evidence based update 2016Marom Bikson, Pnina Grossman, Adantchede Louis Zannou, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Pageof 21